No Detail Found!

Study the Virulence Factors and Patterns of Antibiotics Resistance in Acinetobacter Baumannii Isolated from Hospitalized Patients in Baghdad City.

Author(s)
Nihad KhalaweTektook Collage of Medical and Health Technology, Middle Technical University, Iraq
Abstract
Acinetobacter baumannii is an opportunistic nosocomiala multidrug resistance( MDR) pathogen, so arising largely infections by this bacteria specially in immuno-compromised patients and ability to survive in hospital environments and it became important human pathogen so , virulence factor and antibiotic resistance are playing important role in infections but few studies in Iraq about this bacteria there for present study aimed to study the virulence factors among Acinetobacter baumannii isolated from Hospitalized patients among hospitals in Baghdad city and evaluate the antibiotics resistance in Acinetobacter baumannii isolate. Thirty-nine isolate of Acinetobacter baumannii were isolated during period March to October 2015 from various clinical source from laboratories of bacteriology in different hospitals of Baghdad city then diagnosis and identification by classical methods and vitek 2system, and study virulence factors as form Biofilm; Capsule formation; Pellicle assay; hemolysin production and various enzymes so evaluated the antimicrobial resistance for twelve different antibiotics. Acinetobacter baumannii was more isolated from Wound and Burn swab(38.5%) so (28.2%) isolated from both Urine and sputum , whilst (5.1%) form blood, and high percentage of Acinetobacter baumannii (43.5%) in age group(40-60) years, whilst only (2.5%) in age less than 20 years, as well as high percentage (59.4%) founded in males, Also biochemical test were positive for catalase and citrate, while negative for each of Oxidase, indole , Urease , Lactose fermentation , motility and hemolysin , also all isolate were positive for gelatinase and 21 isolate positive for Protease whilst 29 isolate positive for both Lipase and Capsule as well as 18 isolate positive for Lecithinase and 38, 33 isolate positive for heamolysin production and Pellicle assay respectively . so 32 of Acinetobacter baumannii isolates were positive for biofilm formation, also current study appearance all Acinetobacter baumannii isolates were found resistant to ampicillin, Cefoxitin and tetracycline (100%), whilst low resistance to Imipenem and Piperacillin 58.9, 15.4% respectively. High percentage of Acinetobacter baumannii isolated from burn swab, whilst low percentage from blood so high percentage isolated from age group (40-60) years and frommales patients more isolate compared to females .as well as Acinetobacter baumannii isolates have multiple virulence factors that apparent all Acinetobacter baumannii isolates have gelatinase activity whilst varied result other factors, and highest resistance of isolates to Ampicillin, Cefoxitin and Tetracycline.
Publication Details
Page(s) 19-23
DOI DOI not available
Published Journal: Pakistan Journal of Biotechnology, Volume: 15, Issue: 1, Year: 2018

Request the full text from PASTIC

References
Abdulla , A.A.,A.A.ALthahab,Abed , R.K.,Mahdi and S.S.,Fadhil, 2015.Screening of virulence factors in Acinetobacter baumannii isolated from clinical samples,Int. J. Curr. Res. Aca. Rev 3 128 -134
AL-Warid , R.J.,A.A.AL-Thahab,J. A.B.R, 2014.Isolation and identification of Acinetobacter baumannii in hilla city, 4 4 -8
Bassetti , M.,F.Ginocchio,M.Mikulska, 2011.New treatment options against gram-negative organisms,Crit. Care 15 215 -
Beijerinck , M.W., 2008.Über Pigment bildungbei Essig bakterien,Centr Bakteriol Parasitenk Abt 167 -76
Bergogne-Bérézin , E. and K.J,Towner, 1996.Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features,Clin. Microbiol Rev 9 148 -65
Cai , X.F.,J.M.Sun,L.S , Bao and W.B, Li, 2012.Risk factors and antibiotic resistance of pneumonia caused by multidrug resistant Acinetobacter baumannii in pediatric intensive care unit,World J. Emerg. Med 3 202 -207
Pp, 2004.Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002-2004 (Reprinted from MMWR, 292 2964 -2966
CLSI., 2012.Clinical and Laboratory Standards Institute. Performance standard for antimicrobial susceptibility testing; Twenty-First Informational Supplement, 31 M100 -
Collee , J.G.,A.G.Franser,B.P.Mormion,A.Simmons, 1996.,Mackie and McCartney Practical Medical Microbiology 14th ed. Churchill Livingstone -
DeBreij , A.,L.Dijkshoorn,E.Lagendijk, 2010.Do biofilm formation and interactions with human cells explain the clinical success of Acinetobacter baumannii? PLoS One5: e10732 (, -
Goossens , H.., 2005.European status of resistance in nosocomial infections,Chemotherapy 51 177 -181
Japoni , S.,A.Japoni,S.Farshad,A.A.Ali,M.Jamalidoust, 2007.Association between Existence of Integrons and Multi-Drug Resistance in Acinetobacter Isolated from Patients in Southern Iran,Polish Journal of Microbiology 60 163 -168
Landman , D.,J.M.Quale,D.Mayorga, 2002.Citywide clonal outbreak of multi resistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: The pre-antibiotic era has returned,Arch. Intern. Med 162 1515 -1520
Matos , J.E.,R.J.Harmon,B.E.Langlois, 1995.Lecithinase reaction of Staphylococcus aureus strains of different origin on Baird-Parker medium,Lett. Appl. Microbiol 21 334 -335
McConnell , M.J.,L. Actisand J.N., 2013.Pacho´., Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models,FEMS Microbiol. Rev 37 130 -155
McDonald , L.C.,S.N.Banerjee,W.RJarvis, 1999.Nosocomial Infections Surveillance System,Clin. Infect. Dis 29 1133 -1137
Merritt , J.H.,D.E.Kadouri,G.A.,KowalikT.,QuarlesJ.M.,StevensonB.,Taylor R, 2005.O' Toole, Growing and analyzing static biofilms In: Coico R,Curr. Protoc. Microbiol. John Wiley & Sons. 1B.1 -
Oncül , O.,O.Keskin,H.V.Acar, 2002.Hospital-acquired infections following the 1999 Marmara earth quake,J. Hosp. Infect 51 47 -51
Peleg , A.Y.,H.Seifert,D.L.Paterson, 2008.Acinetobacter baumannii: emergence of a successful pathogen,Clin. Microbiol. Rev 21 538 -82
Perez , F.,A.M , Hujer,Hujer , B.K.,Decker , P.N.,Rather and A.R.,Bonomo, 2007.Global challenge of multi-drug-resistant Acinetobacter baumannii,Antimicrob. Agents. Chemother 51 3471 -3484
Rice , L.B., 2008.Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE,J. Infect. Dis 197 1079 -81
Sofia , C.,R.Angela,S.I.Luminiţa,F.Raluca,T.Iuliana, 2004.Strains Isolated From Hospital Units,Journal of Preventive Medicine 12 35 -42
Tomaras , A.P.,C.W.Dorsey,C.McQueary, 2008.Molecular basis of Acinetobacter virulence and pathogenicity,Acinetobacter Molecular Biology -
Urban , C.,S.Maurer,J.J.Rahal, 2003.Considerations in control and transmission of nosocomial infections due to multi-drug resistant Acinetobacter baumannii,Clin. Infect. Dis 36 1268 -74
Van , L.M.,H.A.Goossens, 2004.Antimicrobial resistance of Acinetobacter spp,in Europe. Clin. Microbiol 10 684 -704
Villegas , M.V.,A.I. Hartstein, 2003.,Control Hosp. Epidemiol 24 284 -95
Wisplinghoff , H., T.,Bischoff , S.M.,Tallent , H.,Seifert , R.P.,Wenzel and M.B. Edmond, 2004.Nosocomial bloodstream infections in US hospitals: analysis of 24, 179 cases from a prospective nationwide surveillance study,Clin. Infect. Dis 39 309 -17
Young , L.S.,A.L.Sabel,C.S.Price, 2007.economic evaluation of an outbreak of clonal multidrug-resistant Acinetobacter baumannii infection in a surgical intensive care unit,Infect. Control Hosp. Epidemiol 28 1247 -1254
0

Citations

0

Downloads

27

Views